All-trans/JJ
retinoic/JJ
acid/NN
and/CC
1/CD
alpha,25-dihydroxyvitamin/NN
D3/NN
co-operate/VBP
to/TO
promote/VB
differentiation/NN
of/IN
the/DT
human/JJ
promyeloid/JJ
leukemia/NN
cell/NN
line/NN
HL60/NN
to/TO
monocytes/NNS
./.

A/DT
basis/NN
for/IN
differentiation/NN
therapy/NN
of/IN
leukemias/NNS
is/VBZ
provided/VBN
by/IN
knowledge/NN
of/IN
agents/NNS
which/WDT
induce/VBP
specific/JJ
lineage/NN
maturation/NN
./.
=====
All-trans/JJ
retinoic/JJ
acid/NN
(/(
RA/NN
)/)
induces/VBZ
differentiation/NN
of/IN
HL60/NN
cells/NNS
to/TO
neutrophils/NNS
and/CC
is/VBZ
used/VBN
to/TO
treat/VB
acute/JJ
promyelocytic/JJ
leukemia/NN
./.
=====
We/PRP
observed/VBD
that/IN
RA/NN
did/VBD
not/RB
induced/VBN
neutrophil/NN
differentiation/NN
in/IN
serum-free/JJ
grown/VBN
HL60/NN
cells/NNS
whereas/IN
50/CD
nM/NN
1/CD
alpha,25-dihydroxyvitamin/NN
D3/NN
(/(
D3/NN
)/)
induced/VBD
maximal/JJ
monocyte/NN
differentiation/NN
./.
=====
Increasing/VBG
RA/NN
concentrations/NNS
reduced/VBD
the/DT
D3/NN
concentration/NN
required/VBN
for/IN
monocyte/NN
differentiation/NN
./.
=====
Cells/NNS
treated/VBN
with/IN
5/CD
nM/NN
D3/NN
showed/VBD
little/JJ
response/NN
,/,
but/CC
differentiated/VBD
maximally/RB
with/IN
5/CD
nM/NN
D3/NN
and/CC
10/CD
nM/NN
RA/NN
./.
=====
The/DT
D3/NN
analogs/NNS
MC903/NN
,/,
EB1089/NN
and/CC
KH1060/NN
were/VBD
more/JJR
potent/JJ
inducers/NNS
of/IN
monocyte/NN
differentiation/NN
./.
=====
The/DT
extent/NN
to/TO
which/WDT
analog/NN
activity/NN
was/VBD
increased/VBN
after/IN
cotreatment/NN
with/IN
RA/NN
was/VBD
inversely/RB
related/JJ
to/TO
potency/NN
./.
=====
Twenty-four/CD
hour/NN
treatment/NN
with/IN
10/CD
nM/NN
RA/NN
primed/VBD
cells/NNS
for/IN
response/NN
to/TO
5/CD
nM/NN
D3/NN
;/:
the/DT
reverse/NN
sequence/NN
being/VBG
ineffective/JJ
./.
=====
Priming/VBG
with/IN
10/CD
nM/NN
RA/NN
,/,
or/CC
subsequent/JJ
treatment/NN
with/IN
D3/NN
(/(
5/CD
nM/NN
)/)
,/,
did/VBD
not/RB
alter/VB
expression/NN
of/IN
mRNAs/NNS
encoding/VBG
receptors/NNS
for/IN
D3/NN
(/(
VDR/NN
)/)
,/,
RA/NN
(/(
RAR/NN
alpha/NN
)/)
or/CC
9-CIS/JJ
RA/NN
(/(
RXR/NN
alpha/NN
,/,
beta/NN
,/,
gamma/NN
)/)
./.
=====
That/IN
RA/NN
promotes/VBZ
both/CC
neutrophil/NN
and/CC
monocyte/NN
differentiation/NN
has/VBZ
implications/NNS
for/IN
the/DT
use/NN
of/IN
RA/NN
and/CC
D3/NN
in/IN
treatment/NN
of/IN
leukemias/NNS
and/CC
provides/VBZ
insight/NN
into/IN
mechanisms/NNS
whereby/WRB
RAR/NN
,/,
VDR/NN
and/CC
RXR/NN
facilitate/VBP
monocyte/NN
differentiation/NN
./.